Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person Heterogeneity of genetic changes associated with acquired crizotinib resistance in ALK-rearranged lung cancer
| Class:Id | LiteratureReference:9713909 |
|---|---|
| _displayName | Heterogeneity of genetic changes associated with acquired crizotinib resistance in ALK-rearranged lung cancer |
| _timestamp | 2021-02-02 01:30:36 |
| author | [Person:9686934] Kim, Soyeon [Person:9713904] Kim, Tae Min [Person:9702241] Kim, Dong-Wan [Person:9713907] Go, Heounjeong [Person:9713905] Keam, Bhumsuk [Person:8853022] Lee, Se-Hoon [Person:9713908] Ku, Ja-Lok [Person:9713902] Chung, Doo Hyun [Person:9713906] Heo, Dae Seog |
| created | [InstanceEdit:9713903] Rothfels, Karen, 2021-02-02 |
| journal | J Thorac Oncol |
| pages | 415-22 |
| pubMedIdentifier | 23344087 |
| title | Heterogeneity of genetic changes associated with acquired crizotinib resistance in ALK-rearranged lung cancer |
| volume | 8 |
| year | 2013 |
| (literatureReference) | [DefinedSet:9700564] crizotinib resistant ALK mutants [plasma membrane] [Homo sapiens] [FailedReaction:9715357] crizotinib-resistant ALK mutants don't bind crizotinib [Homo sapiens] |
| [Change default viewing format] | |
No pathways have been reviewed or authored by Heterogeneity of genetic changes associated with acquired crizotinib resistance in ALK-rearranged lung cancer (9713909)
